1-4 of 4
Laszlo Varoczy, MD PhD
Close
Sort by
Journal Articles

Efficacy and Safety of Venetoclax Combinations in t(11;14) Multiple Myeloma: Real World Data Collected from 7 Hungarian Centers

Virág Réka Szita, MD, Gábor Mikala, MD PhD, János Fábián, MD, Péter Rajnics, MD PhD, László Rejtő, MD PhD, Tamás Szendrei, MD, Hussain Alizadeh, MD PhD DSc, Laszlo Varoczy, MD PhD, Árpád Illés, MD PhD, Tamas Masszi, MD PhD, Gergely Varga, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-139870
Published: 2020
Journal Articles

Real World Data on the Efficacy and Safety of Daratumumab in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Hematology Centers

Gergely Varga, PhD, Tamas Masszi, MD Prof., Péter Farkas, MD, Nikolett Wohner, PhD, Ágnes Bereczki, MD, Zita Borbenyi, MD, Árpád Szomor, MD PhD, Hussain Alizadeh, MD PhD DSc, Erika Szaleczky, PhD, Krisztina Wolf, MD, Tamás Schneider, MD PhD, Mark Plander, PhD, Tamás Szendrei, MD, László Váróczy, MD PhD, Árpád Illés, Ottó Csacsovszky, MD, Zoltán Csukly, MD, Miklos Egyed, MD PhD, Péter Rajnics, PhD, Nora Adamkovich, MD, Szabolcs Kosztolányi, MD, Gábor Mikala, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3257.
https://doi.org/10.1182/blood-2018-99-115039
Published: 2018
Journal Articles

Real World Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program

Gergely Varga, MD PhD, Zsolt Nagy, MD PhD, Szabolcs Kosztolányi, MD, Árpád Szomor, MD PhD, Tamás Schneider, MD PhD, Beáta Deák, MD PhD, Krisztina Wolf, MD, Márk Plander, MD PhD, Tamás Szendrei, MD, László Váróczy, MD PhD, Árpád Illés, MD PhD, Árpád Bátai, MD, Mónika Pető, MD, János Fábián, MD, Tamas Masszi, MD PhD, Gabor Mikala, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1865.
https://doi.org/10.1182/blood.V130.Suppl_1.1865.1865
Published: 2017
Journal Articles

Retrospective Comparison Of Autologous Transplantation Results Of Decreased MNC Viability Graft Cases (n=52) To Good Viability Graft Cases (n=306), a Single Centre Experience

Mariann Szarvas, Gabriella Kovács, Zita Korondán, Peter Batar, MD, PhD, Attila Kiss, MD, PhD, László Rejtö, MD, PhD, Gyula Reményi, MD, Róbert Szász, MD, László Váróczy, MD, PhD, Árpád Illés, MD, PhD, DSc, Miklós Udvardy, MD, PhD, DSc
Journal: Blood
Blood (2013) 122 (21): 2164.
https://doi.org/10.1182/blood.V122.21.2164.2164
Published: 2013